Gene Overview
flowchart TD
PIN1["PIN1"] -->|"modulates"| TRIM32["TRIM32"]
PIN1["PIN1"] -->|"phosphorylates"| TRIM32["TRIM32"]
PIN1["PIN1"] -->|"binds"| SUMO2_3["SUMO2/3"]
PIN1["PIN1"] -->|"binds"| SENP1["SENP1"]
PIN1["PIN1"] -->|"phosphorylates"| ANXA2["ANXA2"]
PIN1["PIN1"] -->|"associated with"| Alzheimer_s_disease["Alzheimer's disease"]
PIN1["PIN1"] -->|"regulates"| Aging["Aging"]
PIN1["PIN1"] -->|"regulates"| Neurodegeneration["Neurodegeneration"]
PIN1["PIN1"] -->|"regulates"| Als["Als"]
PIN1["PIN1"] -->|"regulates"| Cancer["Cancer"]
PIN1["PIN1"] -->|"regulates"| Longevity["Longevity"]
PIN1["PIN1"] -->|"regulates"| Ms["Ms"]
PIN1["PIN1"] -->|"regulates"| Tumor["Tumor"]
PIN1["PIN1"] -->|"treats"| Tumor["Tumor"]
style PIN1 fill:#4fc3f7,stroke:#333,color:#000PIN1 (Peptidyl-prolyl cis-trans Isomerase NIMA-Interacting 1) is a peptidyl-prolyl cis-trans isomerase that specifically binds to phosphorylated serine/threonine-proline motifs and catalyzes the isomerization of peptide bonds. PIN1 is a critical regulator of protein function in multiple signaling pathways and has been implicated in Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions.
Gene Information
| Symbol | PIN1 |
|---|---|
| Full Name | Peptidyl-prolyl cis-trans Isomerase NIMA-Interacting 1 |
| Chromosomal Location | 19p13.13 |
| NCBI Gene ID | [5300](https://www.ncbi.nlm.nih.gov/gene/5300) |
| OMIM | [607712](https://www.omim.org/entry/607712) |
| Ensembl ID | ENSG00000100429 |
| UniProt ID | [Q13535](https://www.uniprot.org/uniprot/Q13535) |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Cancer](/diseases/cancer) |
Function
PIN1 is a unique peptidyl-prolyl cis-trans isomerase (PPIase) that catalyzes the isomerization of peptide bonds preceding phosphorylated serine or threonine residues. This post-translational modification can dramatically alter protein conformation and function.
Structural Features
-
WW Domain: N-terminal domain that recognizes phosphorylated serine/threonine-proline motifs
-
PPIase Domain: C-terminal catalytic domain that catalyzes cis-trans isomerization
-
Substrate Specificity: Highly specific for pSer/Thr-Pro motifs, unique among PPIases
Biological Functions
-
Tau Phosphorylation Regulation: PIN1 binds to phosphorylated tau (p-tau) and promotes proper tau folding, preventing aggregation
-
Cell Cycle Regulation: Controls entry and progression through mitosis via regulation of mitotic proteins
-
Signal Transduction: Modulates signaling pathways including MAPK, PI3K/AKT, and Wnt/β-catenin
-
Transcriptional Regulation: Influences transcription factor activity including p53, c-Jun, and NF-κB
-
Protein Quality Control: Aids in proper folding and trafficking of proteins
Disease Associations
Alzheimer’s Disease
PIN1 plays a complex role in AD pathophysiology:
-
Beneficial Function: Catalyzes isomerization of phosphorylated tau, promoting proper tau function
-
Pathogenic Dysfunction: In AD brain, PIN1 activity is reduced, leading to tau hyperphosphorylation and neurofibrillary tangle formation
-
Therapeutic Target: PIN1 activators are being explored as potential AD therapeutics
-
Reference: Lu et al., Science (1999)
Parkinson’s Disease
-
PIN1 levels are altered in PD brains
-
May regulate α-synuclein phosphorylation and aggregation
-
Reference: Sala et al., J. Neurochem. (2009)
Cancer
-
Overexpression in multiple cancers including breast, prostate, and lung
-
Promotes cell proliferation and survival
-
Reference: Lu et al., Nat. Rev. Cancer (2009)
Expression
Brain Expression
-
Cerebral Cortex: Moderate to high expression, particularly in pyramidal neurons
-
Hippocampus: High expression in CA1-CA3 regions and dentate gyrus
-
Substantia Nigra: Present in dopaminergic neurons
-
Cerebellum: Moderate expression in Purkinje cells
Cellular Localization
-
Nuclear: Predominantly nuclear localization
-
Cytoplasmic: Also present in cytoplasm
-
Neuronal Processes: Localizes to dendritic spines
Common Variants
| Variant | Function | Disease Association |
|---|---|---|
| S16E | Polymorphism | Possible altered activity |
| Q33K | Polymorphism | None confirmed |
| H89A | Loss of function | Research tool |
Therapeutic Implications
Drug Development
-
PIN1 Activators: Pharmaceutical compounds that enhance PIN1 activity for AD treatment
-
PIN1 Inhibitors: Being developed for cancer therapy
Biomarker Potential
-
PIN1 expression in CSF may serve as a biomarker for neurodegeneration
-
Reference: Matsuda et al., J. Alzheimers Dis. (2015)
See Also
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.